Pediatric Vaccines Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis

1.    Introduction

2.    Research Methodology
3.    Executive Summary

4.    Market Dynamics

4.1    Growth Driver
4.2    Challenges

5.    Pediatric (Infant) Vaccines Market
6.    Pediatric Vaccinated Numbers

7.    Market & Numbers Share – Pediatric Vaccine Analysis

7.1    Pediatric Vaccine Market Share
7.2    Pediatric Vaccinated Population Share
7.3    By Regions Market share

8.    Disease wise – Pediatric (Infants) Vaccines Market

8.1    Influenza
8.2    MMR (Measles, Mumps, and Rubella Vaccine)
8.3    Pneumococcal
8.4    Meningococcal
8.5    Hepatitis
8.6    DTaP
8.7    Haemophilus Influenzae Type B (HIB)
8.8    Combos (Combination)
8.9    Polio
8.10    Rotavirus
8.11    Varicella

9.    Disease wise – Numbers of Vaccinated Pediatric (Infants)

9.1    Influenza
9.2    MMR
9.3    Pneumococcal
9.4    Meningococcal
9.5    Hepatitis
9.6    DTaP
9.7    Hib (Haemophilus Influenzae Type B)
9.8    Combos (Combination Vaccines)
9.9    Polio
9.10    Rotavirus
9.11    Varicella

10.    By Region– Pediatric (Infants) Vaccines Market and Number

10.1    North America

10.1.1    Market
10.1.2    Number

10.2    Europe

10.2.1    Market
10.2.2    Number

10.3    Asia Pacific

10.3.1    Market
10.3.2    Number

10.4    Latin America

10.4.1    Market
10.4.2    Number

10.5    Middle East and Africa

10.5.1    Market
10.5.2    Number

11.    Mergers and Acquisitions in the Vaccine Industry

12.    Vaccines and Regulator’s Interventions

12.1    Making and Meeting Standards of Quality and Safety
12.2    Vaccine Funding

13.    Vaccines – Products and Pipeline

13.1    GSK Vaccine Product Pipeline
13.2    Merck Vaccine Product Pipeline
13.3    Sanofi Vaccine Product Pipeline
13.4    Pfizer Vaccine Product Pipeline

14.    Porters Five Forces

14.1    Overview
14.2    Bargaining Power of Buyers
14.3    Bargaining Power of Suppliers
14.4    Degree of Competition
14.5    Threat of New Entrants
14.6    Threat of Substitutes

15.    Company Analysis

15.1    GlaxoSmithKline, plc.

15.1.1    Overview
15.1.2    Recent Development
15.1.3    Sales Analysis

15.2    Merck & Co.

15.2.1    Overview
15.2.2    Recent Development
15.2.3    Sales Analysis

15.3    Sanofi Pasteur’s

15.3.1    Overview
15.3.2    Recent Development
15.3.3    Sales Analysis

15.4    Pfizer, Inc.’s

15.4.1    Overview
15.4.2    Recent Development
15.4.3    Sales Analysis

15.5    CSL Limited

15.5.1    Overview
15.5.2    Recent Development
15.5.3    Sales Analysis

List Of Figures:

Figure-01:        Global Pediatric (Infant) Vaccines Market (Million US$), 2016 – 2021
Figure-02:        Global – Forecast for Pediatric (Infant) Vaccines Market (Million US$), 2022 – 2027
Figure-03:        Global – Pediatric (Infant) Vaccines Number (Million), 2016 – 2021
Figure-04:        Global – Forecast for Pediatric (Infant) Vaccines Number (Million), 2022 – 2027
Figure-05:        Disease wise – Influenza Market (Million US$), 2016 – 2021
Figure-06:        Disease wise – Forecast for Influenza Market (Million US$), 2022 – 2027
Figure-07:        Disease wise – MMR (Measles, Mumps, and Rubella Vaccine) Market (Million US$), 2016 – 2021
Figure-08:        Disease wise – Forecast for MMR (Measles, Mumps, and Rubella Vaccine) Market (Million US$), 2022 – 2027
Figure-09:        Disease wise – Pneumococcal Market (Million US$), 2016 – 2021
Figure-10:        Disease wise – Forecast for Pneumococcal Market (Million US$), 2022 – 2027
Figure-11:        Disease wise – Meningococcal Market (Million US$), 2016 – 2021
Figure-12:        Disease wise – Forecast for Meningococcal Market (Million US$), 2022 – 2027
Figure-13:        Disease wise – Hepatitis Market (Million US$), 2016 – 2021
Figure-14:        Disease wise – Forecast for Hepatitis Market (Million US$), 2022 – 2027
Figure-15:        Disease wise – DTaP Market (Million US$), 2016 – 2021
Figure-16:        Disease wise – Forecast for DTaP Market (Million US$), 2022 – 2027
Figure-17:        Disease wise – Haemophilus Influenzae Type B (HIB) Market (Million US$), 2016 – 2021
Figure-18:        Disease wise – Forecast for Haemophilus Influenzae Type B (HIB) Market (Million US$), 2022 – 2027
Figure-19:        Disease wise – Combos (Combination) Market (Million US$), 2016 – 2021
Figure-20:        Disease wise – Forecast for Combos (Combination) Market (Million US$), 2022 – 2027
Figure-21:        Disease wise – Polio Market (Million US$), 2016 – 2021
Figure-22:        Disease wise – Forecast for Polio Market (Million US$), 2022 – 2027
Figure-23:        Disease wise – Rotavirus Market (Million US$), 2016 – 2021
Figure-24:        Disease wise – Forecast for Rotavirus Market (Million US$), 2022 – 2027
Figure-25:        Disease wise – Varicella Market (Million US$), 2016 – 2021
Figure-26:        Disease wise – Forecast for Varicella Market (Million US$), 2022 – 2027
Figure-27:        Disease wise – Influenza Number (Million), 2016 – 2021
Figure-28:        Disease wise – Forecast for Influenza Number (Million), 2022 – 2027
Figure-29:        Disease wise – MMR Number (Million), 2016 – 2021
Figure-30:        Disease wise – Forecast for MMR Number (Million), 2022 – 2027
Figure-31:        Disease wise – Pneumococcal Number (Million), 2016 – 2021
Figure-32:        Disease wise – Forecast for Pneumococcal Number (Million), 2022 – 2027
Figure-33:        Disease wise – Meningococcal Number (Million), 2016 – 2021
Figure-34:        Disease wise – Forecast for Meningococcal Number (Million), 2022 – 2027
Figure-35:        Disease wise – Hepatitis Number (Million), 2016 – 2021
Figure-36:        Disease wise – Forecast for Hepatitis Number (Million), 2022 – 2027
Figure-37:        Disease wise – DTaP Number (Million), 2016 – 2021
Figure-38:        Disease wise – Forecast for DTaP Number (Million), 2022 – 2027
Figure-39:        Disease wise – Hib (Haemophilus Influenzae Type B) Number (Million), 2016 – 2021
Figure-40:        Disease wise – Forecast for Hib (Haemophilus Influenzae Type B) Number (Million), 2022 – 2027
Figure-41:        Disease wise – Combos (Combination Vaccines) Number (Million), 2016 – 2021
Figure-42:        Disease wise – Forecast for Combos (Combination Vaccines) Number (Million), 2022 – 2027
Figure-43:        Disease wise – Polio Number (Million), 2016 – 2021
Figure-44:        Disease wise – Forecast for Polio Number (Million), 2022 – 2027
Figure-45:        Disease wise – Rotavirus Number (Million), 2016 – 2021
Figure-46:        Disease wise – Forecast for Rotavirus Number (Million), 2022 – 2027
Figure-47:        Disease wise – Varicella Number (Million), 2016 – 2021
Figure-48:        Disease wise – Forecast for Varicella Number (Million), 2022 – 2027
Figure-49:        GlaxoSmithKline, plc.’s Vaccines Sales – Global Revenue (Million US$), 2016 – 2021
Figure-50:        GlaxoSmithKline, plc.’s Vaccines Sales – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-51:         Merck & Co. Vaccines Sales – Global Revenue (Million US$), 2016 – 2021
Figure-52:        Merck & Co. Vaccines Sales – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-53:        Sanofi Pasteur’s Vaccines Sales – Global Revenue (Million US$), 2016 – 2021
Figure-54:        Sanofi Pasteur’s Vaccines Sales – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-55:        Pfizer, Inc.’s Vaccines Sales – Global Revenue (Million US$), 2016 – 2021
Figure-56:        Pfizer, Inc.’s Vaccines Sales – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-57:        Thoracic Aortic Aneurysm (TAA)CSL Limited sales – Global Revenue (Million US$), 2016 – 2021
Figure-58:        Thoracic Aortic Aneurysm (TAA)CSL Limited sales – Forecast for Global Revenue (Million US$), 2022 – 2027

List Of Tables:

Table-01:        Global – Pediatric Vaccines Market Share (Percent), 2016 – 2021
Table-02:        Global – Forecast for Pediatric Vaccines Market Share (Percent), 2022 – 2027
Table-03:        Global – Pediatric Vaccines Population Share (Percent), 2016 – 2021
Table-04:        Global – Forecast for Pediatric Vaccines Population Share (Percent), 2022 – 2027